| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Strategy &External Aff.
1 company
Economides Vassiliki is a SVP, Strategy &External Aff. at Kezar Life Sciences, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $56K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | KZR Kezar Life Sciences, Inc. | SVP, Strategy &External Aff. | Buy | 5,769 | $2.60 | $14,999.40 | +320.3% | |
| Aug 20, 2019 | KZR Kezar Life Sciences, Inc. | SVP, Strategy &External Aff. | Buy | 350 | $4.41 | $1,543.57 | +24.1% | |
| Aug 9, 2019 | KZR Kezar Life Sciences, Inc. | SVP, Strategy &External Aff. | Buy | 1,020 | $4.96 | $5,057.36 | +236.7% | |
| Jul 22, 2019 | KZR Kezar Life Sciences, Inc. | SVP, Strategy &External Aff. | Buy | 431 | $5.82 | $2,508.72 | New | |
| May 30, 2019 | KZR Kezar Life Sciences, Inc. | SVP, Strategy &External Aff. | Buy | 750 | $10.19 | $7,642.50 | +7.1% |